編集者
目次
Important safety information including dosage, side effects, and precautions of Bofutsushosan.
Dosage & Administration
-For adults, take 1 packet 2-3 times a day.
-Take with lukewarm water on an empty stomach.
-Store in a cool, dry place away from direct sunlight.
-Do not use this product after the expiration date.
Side Effects
Although side effects are rare, the following may occur. If you experience any of these symptoms, discontinue use and consult your doctor immediately.
- Skin: Rash, redness, itching
- Gastrointestinal: Nausea, vomiting, loss of appetite, abdominal discomfort, abdominal distension, diarrhea with severe abdominal pain, abdominal pain
- Nervous system: Dizziness
*Serious Side Effects
Rarely, the following serious side effects may occur. If you experience any of these symptoms, consult your doctor immediately.
-Interstitial pneumonia, pseudoaldosteronism, myopathy, hepatic dysfunction, jaundice, mesenteric arteriosclerosis, among others.
Precautions
Consult your doctor before taking this medication if you have any of the following conditions:
- Diarrhea, loose stool, weak stomach, loss of appetite, nausea, vomiting, convalescence, significant physical weakness, excessive sweating, angina pectoris, myocardial infarction or other circulatory disorders, history of allergy to drugs, severe hypertension, severe kidney impairment, urinary disorders, hyperthyroidism.
*Medicines prescribed in this department are not covered by the Adverse Reactions Relief System.
Approval status in Japan
Bofutsushosan is not approved in Japan for weight loss.
*Medicines prescribed by this department are not covered by the Adverse Reactions Relief System.
Availability of approved medicines that have the same active ingredients in Japan
There are no domestically approved drugs that have the same active ingredient as Bofutsushosan for weight loss.
Means of acquisition
Our affiliated clinic physicians purchase through a domestic pharmaceutical distributor.
Information on safety and approval in other countries
No serious safety information has been reported in other countries.